Trial reportJournal of cutaneous medicine and surgery
Evaluating the Impact of the Vulvar Quality of Life Index for New Patient Dermatology Assessments.
Trial report in Journal of cutaneous medicine and surgery. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe prevalence of vulvar diseases has a significant impact on quality of life (QoL). Measurement may not be consistently collected during assessments. Incorporating a QoL measurement tool may help optimize patient-centred care.
objectiveTo determine the impact of the validated Vulvar Quality of Life Index (VQLI) questionnaire during consultation assessments.
methodsA randomized controlled trial from a single dermatology centre was completed over 10 months. The intervention group completed the VQLI at the baseline/initial appointment, and both the intervention and control groups completed the questionnaire at follow-up, with these scores compared. Secondary outcomes compared scores within the intervention group; analyzed treatment adherence; and surveyed self-reported symptom improvement, whether patient health-related concerns were addressed, and well-being. Data were analyzed descriptively, with significance between means and proportions assessed using
resultsForty-two patients participated. Scores within the intervention group, baseline (18) versus follow-up (8.3), were statistically significant. Follow-up VQLI scores in the intervention group (n = 23), 8.3, trended lower than the control (n = 19), 12.8, but were not statistically significant (
conclusionsIn addition to the use of VQLI in vulvar dermatology assessments as an aid in identifying the impact of vulvar conditions on QoL, we recommend its use to improve the patients' sense of well-being.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.